Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
Authors
Keywords
Amyotrophic lateral sclerosis, Inflammatory diseases, Cytokines, Inflammation, Enzyme-linked immunoassays, Adverse events, Motor neurons, Pilot studies
Journal
PLoS One
Volume 10, Issue 10, Pages e0139684
Publisher
Public Library of Science (PLoS)
Online
2015-10-08
DOI
10.1371/journal.pone.0139684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Controversies and priorities in amyotrophic lateral sclerosis
- (2013) Martin R Turner et al. LANCET NEUROLOGY
- Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases
- (2013) Annemarie Hübers et al. NEUROBIOLOGY OF AGING
- ALSUntangled No. 19: Sodium chlorite
- (2013) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Online assessment of ALS functional rating scale compares well to in-clinic evaluation: A prospective trial
- (2012) André Maier et al. Amyotrophic Lateral Sclerosis
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Peripheral nerve inflammation in ALS mice: cause or consequence
- (2012) O. Kano et al. NEUROLOGY
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
- (2011) Thomas Philips et al. LANCET NEUROLOGY
- Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice
- (2010) Margaret Wong et al. HUMAN MOLECULAR GENETICS
- Intravenous Anakinra can Achieve Experimentally Effective Concentrations in the Central Nervous System within a Therapeutic Time Window: Results of a Dose-Ranging Study
- (2010) James Galea et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Progression in ALS is not linear but is curvilinear
- (2010) Paul H. Gordon et al. JOURNAL OF NEUROLOGY
- Mutant superoxide dismutase 1-induced IL-1 accelerates ALS pathogenesis
- (2010) F. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis
- (2009) D. Keizman et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
- (2009) Elijah W. Stommel et al. Amyotrophic Lateral Sclerosis
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
- (2009) I. M. Chiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Causes of death in a post‐mortem series of ALS patients
- (2008) Philippe Corcia et al. Amyotrophic Lateral Sclerosis
- Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study
- (2008) J. Gil et al. EUROPEAN JOURNAL OF NEUROLOGY
- Thalidomide causes sinus bradycardia in ALS
- (2008) T. Meyer et al. JOURNAL OF NEUROLOGY
- Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model
- (2008) Gabriella Dobrowolny et al. NEUROLOGICAL RESEARCH
- A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis
- (2008) R. M. Mitchell et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started